Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
40S small subunit processome assembly factor 1 (FSAF1) is a protein involved in the biogenesis of the ribosomal small subunit in eukaryotes, acting as part of the small-subunit processome complex. It facilitates RNA binding and is important for proper assembly and processing of the nascent pre-rRNA, but is not characterized as a therapeutic target, receptor, enzyme, or transporter. Its major function is in ribosome production, rather than in modulating signaling pathways or serving as a druggable protein. FSAF1 is encoded by the C1orf131 gene and has no known direct links to current clinical biomarkers, drugs, or mechanisms of pharmacological action[1]. Key points supporting this assessment: - The canonical full name is "40S small subunit processome assembly factor 1"[1]. - The canonical abbreviation is "FSAF1"[1]. - It is not a classical drug target (such as a receptor, enzyme, transport protein, or known actionable disease protein)[1]. - Alternative designations in the literature and databases include C1orf131 and related synonyms, reflecting historic gene nomenclature[1]. - The protein's primary molecular function is in **ribosome assembly via RNA binding and ribosomal RNA processing**[1]. - No direct disease-modifying role, no known small-molecule drug interactions, and no defined mechanism of drug action reported; not reported as a biomarker or as associated with therapeutic safety issues[1]. Notes on incorrectness: - "FSAF1" and the associated full name are often confused with "FAF1" (Fas-associated factor 1), which is a death-promoting protein involved in apoptosis and a known candidate cancer target[5]. This query refers to a different, non-druggable, ribosome biogenesis factor, and not a therapeutic target. - No evidence was found for FSAF1 being a receptor, enzyme, or protein of drug development interest. If you are seeking information about Fas-associated factor 1 (FAF1), which is a distinct clinically relevant target linked to apoptosis, cancer, and drug modulation, clarify the abbreviation, as this is a separate entry with distinct biological functions and target utility[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 40S small subunit processome assembly factor 1 (FSAF1).